These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35343786)

  • 1. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8.
    Wu X; Xia T; Shin WJ; Yu KM; Jung W; Herrmann A; Foo SS; Chen W; Zhang P; Lee JS; Poo H; Comhair SAA; Jehi L; Choi YK; Ensser A; Jung JU
    mBio; 2022 Apr; 13(2):e0040222. PubMed ID: 35343786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor.
    Ponde NO; Shoger KE; Khatun MS; Sarkar MK; Dey I; Taylor TC; Cisney RN; Arunkumar SP; Gudjonsson JE; Kolls JK; Gottschalk RA; Gaffen SL
    J Immunol; 2023 Jul; 211(2):252-260. PubMed ID: 37265402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unconventional secretion of unglycosylated ORF8 is critical for the cytokine storm during SARS-CoV-2 infection.
    Lin X; Fu B; Xiong Y; Xing N; Xue W; Guo D; Zaky M; Pavani K; Kunec D; Trimpert J; Wu H
    PLoS Pathog; 2023 Jan; 19(1):e1011128. PubMed ID: 36689483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2.
    Zinzula L
    Biochem Biophys Res Commun; 2021 Jan; 538():116-124. PubMed ID: 33685621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unique ORF8 protein from SARS-CoV-2 binds to human dendritic cells and induces a hyper-inflammatory cytokine storm.
    Hamdorf M; Imhof T; Bailey-Elkin B; Betz J; Theobald SJ; Simonis A; Di Cristanziano V; Gieselmann L; Dewald F; Lehmann C; Augustin M; Klein F; Alejandre Alcazar MA; Rongisch R; Fabri M; Rybniker J; Goebel H; Stetefeld J; Brachvogel B; Cursiefen C; Koch M; Bock F
    J Mol Cell Biol; 2024 Apr; 15(10):. PubMed ID: 37891014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNγ-Induced Antiviral Gene Expression in Human Lung Epithelial Cells.
    Geng H; Subramanian S; Wu L; Bu HF; Wang X; Du C; De Plaen IG; Tan XD
    Front Immunol; 2021; 12():679482. PubMed ID: 34177923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
    Wang X; Wang W; Wang T; Wang J; Jiang Y; Wang X; Qiu Z; Feng N; Sun W; Li C; Yang S; Xia X; He H; Gao Y
    J Virol; 2023 Mar; 97(3):e0001123. PubMed ID: 36877072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 ORF8: A Rapidly Evolving Immune and Viral Modulator in COVID-19.
    Arduini A; Laprise F; Liang C
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 ORF8 is a viral cytokine regulating immune responses.
    Kohyama M; Suzuki T; Nakai W; Ono C; Matsuoka S; Iwatani K; Liu Y; Sakai Y; Nakagawa A; Tomii K; Ohmura K; Okada M; Matsuura Y; Ohshima S; Maeda Y; Okamoto T; Arase H
    Int Immunol; 2023 Jan; 35(1):43-52. PubMed ID: 36053553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2.
    Hassan SS; Kodakandla V; Redwan EM; Lundstrom K; Pal Choudhury P; Abd El-Aziz TM; Takayama K; Kandimalla R; Lal A; Serrano-Aroca Á; Azad GK; Aljabali AAA; Palù G; Chauhan G; Adadi P; Tambuwala M; Brufsky AM; Baetas-da-Cruz W; Barh D; Azevedo V; Bazan NG; Andrade BS; Santana Silva RJ; Uversky VN
    PeerJ; 2022; 10():e13136. PubMed ID: 35341060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses.
    Tan Y; Schneider T; Leong M; Aravind L; Zhang D
    mBio; 2020 May; 11(3):. PubMed ID: 32471829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte response to SARS-CoV-2 protein ORF8 is associated with severe COVID-19 infection in patients with chronic lymphocytic leukemia.
    Ruan GJ; Wu X; Gwin KA; Manske MK; Abeykoon JP; Bhardwaj V; Witter TL; Schellenberg MJ; Rabe KG; Kay NE; Parikh SA; Witzig TE
    Haematologica; 2024 Sep; 109(9):2884-2892. PubMed ID: 38654668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
    Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
    J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles.
    Gamage AM; Tan KS; Chan WOY; Liu J; Tan CW; Ong YK; Thong M; Andiappan AK; Anderson DE; Wang Y; Wang LF
    PLoS Pathog; 2020 Dec; 16(12):e1009130. PubMed ID: 33284849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant.
    Ohki S; Imamura T; Higashimura Y; Matsumoto K; Mori M
    Biochem Biophys Res Commun; 2021 Jul; 563():92-97. PubMed ID: 34062392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Accessory Protein ORF8 Targets the Dimeric IgA Receptor pIgR.
    Laprise F; Arduini A; Duguay M; Pan Q; Liang C
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein.
    Wang X; Lam JY; Wong WM; Yuen CK; Cai JP; Au SW; Chan JF; To KKW; Kok KH; Yuen KY
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 ORF8 modulates lung inflammation and clinical disease progression.
    McGrath ME; Xue Y; Taylor L; Dillen C; Ardanuy J; Gonzalez-Juarbe N; Baracco L; Kim R; Hart R; Assad-Garcia N; Vashee S; Frieman MB
    PLoS Pathog; 2024 May; 20(5):e1011669. PubMed ID: 38781259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 ORF8 as a Modulator of Cytokine Induction: Evidence and Search for Molecular Mechanisms.
    Móvio MI; Almeida GWC; Martines IDGL; Barros de Lima G; Sasaki SD; Kihara AH; Poole E; Nevels M; Carlan da Silva MC
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38275971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 ORF8 accessory protein is a virulence factor.
    Bello-Perez M; Hurtado-Tamayo J; Mykytyn AZ; Lamers MM; Requena-Platek R; Schipper D; Muñoz-Santos D; Ripoll-Gómez J; Esteban A; Sánchez-Cordón PJ; Enjuanes L; Haagmans BL; Sola I
    mBio; 2023 Oct; 14(5):e0045123. PubMed ID: 37623322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.